These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29266629)

  • 1. Human Mesenchymal Stem Cell Failure to Adapt to Glucose Shortage and Rapidly Use Intracellular Energy Reserves Through Glycolysis Explains Poor Cell Survival After Implantation.
    Moya A; Paquet J; Deschepper M; Larochette N; Oudina K; Denoeud C; Bensidhoum M; Logeart-Avramoglou D; Petite H
    Stem Cells; 2018 Mar; 36(3):363-376. PubMed ID: 29266629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quiescence Preconditioned Human Multipotent Stromal Cells Adopt a Metabolic Profile Favorable for Enhanced Survival under Ischemia.
    Moya A; Larochette N; Paquet J; Deschepper M; Bensidhoum M; Izzo V; Kroemer G; Petite H; Logeart-Avramoglou D
    Stem Cells; 2017 Jan; 35(1):181-196. PubMed ID: 27578059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proangiogenic and prosurvival functions of glucose in human mesenchymal stem cells upon transplantation.
    Deschepper M; Manassero M; Oudina K; Paquet J; Monfoulet LE; Bensidhoum M; Logeart-Avramoglou D; Petite H
    Stem Cells; 2013 Mar; 31(3):526-35. PubMed ID: 23225732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia.
    Deschepper M; Oudina K; David B; Myrtil V; Collet C; Bensidhoum M; Logeart-Avramoglou D; Petite H
    J Cell Mol Med; 2011 Jul; 15(7):1505-14. PubMed ID: 20716129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of hypoxia on metabolic switch and osteogenic differentiation of human mesenchymal stem cells.
    Hsu SH; Chen CT; Wei YH
    Stem Cells; 2013 Dec; 31(12):2779-88. PubMed ID: 23733376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment.
    Mylotte LA; Duffy AM; Murphy M; O'Brien T; Samali A; Barry F; Szegezdi E
    Stem Cells; 2008 May; 26(5):1325-36. PubMed ID: 18308942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen Tension Regulates Human Mesenchymal Stem Cell Paracrine Functions.
    Paquet J; Deschepper M; Moya A; Logeart-Avramoglou D; Boisson-Vidal C; Petite H
    Stem Cells Transl Med; 2015 Jul; 4(7):809-21. PubMed ID: 25979862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of human dental pulp stem cells and human bone marrow-derived mesenchymal stem cells on ischemic human astrocytes in vitro.
    Song M; Jue SS; Cho YA; Kim EC
    J Neurosci Res; 2015 Jun; 93(6):973-83. PubMed ID: 25663284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetoacetate is a more efficient energy-yielding substrate for human mesenchymal stem cells than glucose and generates fewer reactive oxygen species.
    Board M; Lopez C; van den Bos C; Callaghan R; Clarke K; Carr C
    Int J Biochem Cell Biol; 2017 Jul; 88():75-83. PubMed ID: 28483672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model.
    Higuera G; Schop D; Janssen F; van Dijkhuizen-Radersma R; van Boxtel T; van Blitterswijk CA
    Tissue Eng Part A; 2009 Sep; 15(9):2653-63. PubMed ID: 19207045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α is upregulated in human mesenchymal stem cells.
    Palomäki S; Pietilä M; Laitinen S; Pesälä J; Sormunen R; Lehenkari P; Koivunen P
    Stem Cells; 2013 Sep; 31(9):1902-9. PubMed ID: 23744828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density-Dependent Metabolic Heterogeneity in Human Mesenchymal Stem Cells.
    Liu Y; Muñoz N; Bunnell BA; Logan TM; Ma T
    Stem Cells; 2015 Nov; 33(11):3368-81. PubMed ID: 26274841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low ATP level is sufficient to maintain the uncommitted state of multipotent mesenchymal stem cells.
    Buravkova LB; Rylova YV; Andreeva ER; Kulikov AV; Pogodina MV; Zhivotovsky B; Gogvadze V
    Biochim Biophys Acta; 2013 Oct; 1830(10):4418-25. PubMed ID: 23742825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of the WNT-Signaling Modulators BIO and PKF118-310 on the Chondrogenic Differentiation of Human Mesenchymal Stem Cells.
    Huang X; Zhong L; Hendriks J; Post JN; Karperien M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29438298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermoreversible hyaluronan-based hydrogel supports in vitro and ex vivo disc-like differentiation of human mesenchymal stem cells.
    Peroglio M; Eglin D; Benneker LM; Alini M; Grad S
    Spine J; 2013 Nov; 13(11):1627-39. PubMed ID: 23830827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds.
    Rai B; Lin JL; Lim ZX; Guldberg RE; Hutmacher DW; Cool SM
    Biomaterials; 2010 Nov; 31(31):7960-70. PubMed ID: 20688388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury.
    Chang W; Song BW; Lim S; Song H; Shim CY; Cha MJ; Ahn DH; Jung YG; Lee DH; Chung JH; Choi KD; Lee SK; Chung N; Lee SK; Jang Y; Hwang KC
    Stem Cells; 2009 Sep; 27(9):2283-92. PubMed ID: 19544472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versatility of microglial bioenergetic machinery under starving conditions.
    Nagy AM; Fekete R; Horvath G; Koncsos G; Kriston C; Sebestyen A; Giricz Z; Kornyei Z; Madarasz E; Tretter L
    Biochim Biophys Acta Bioenerg; 2018 Mar; 1859(3):201-214. PubMed ID: 29273412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia is the prime but not the only cause of human multipotent stromal cell death in tissue-engineered constructs in vivo.
    Becquart P; Cambon-Binder A; Monfoulet LE; Bourguignon M; Vandamme K; Bensidhoum M; Petite H; Logeart-Avramoglou D
    Tissue Eng Part A; 2012 Oct; 18(19-20):2084-94. PubMed ID: 22578283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoenergetic Dysfunction Triggers a Rapid Compensatory Increase in Steady-State Glucose Flux.
    Liemburg-Apers DC; Schirris TJ; Russel FG; Willems PH; Koopman WJ
    Biophys J; 2015 Oct; 109(7):1372-86. PubMed ID: 26445438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.